ZEJULA 300 mg/1 (Niraparib TABLET, FILM COATED) 300 mg/1

ZEJULA 300 mg is a prescription medication containing niraparib, used for specific therapeutic purposes. This oral tablet is designed to support targeted treatment regimens as directed by healthcare professionals.

Strength

300 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0173-0915-61)

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZEJULA 300 mg tablets are primarily used in the management of certain conditions related to DNA repair mechanisms. Niraparib, the active ingredient, is often utilized in maintenance therapy for patients who have responded to prior treatment. The medication is prescribed to help maintain treatment effects and manage symptoms associated with these conditions.

Side Effects

Common effects of ZEJULA 300 mg may include fatigue, nausea, and changes in blood cell counts. Some individuals might experience gastrointestinal discomfort or other mild to moderate symptoms. It is important to discuss any persistent or severe effects with a healthcare provider.

Precautions & Warnings

ZEJULA 300 mg should be handled with care, following the instructions provided by a healthcare professional. It is essential to store the medication properly and adhere to the prescribed regimen. Patients should inform their healthcare provider about any existing medical conditions or other medications they are taking.

Avoid Interactions

ZEJULA 300 mg may interact with certain medications, including those that affect liver enzymes or blood cell production. It is important to avoid alcohol and discuss all current medications with a healthcare provider to prevent potential interactions. Always follow professional advice regarding the use of niraparib.

Frequently Asked Questions

ZEJULA 300 mg is used in maintenance therapy for certain conditions related to DNA repair mechanisms, often following a response to prior treatment.

ZEJULA 300 mg should be taken orally, as directed by a healthcare professional. Always follow the prescribed dosage and administration instructions.

Common side effects may include fatigue, nausea, and changes in blood cell counts. Persistent or severe symptoms should be discussed with a healthcare provider.

ZEJULA 300 mg may interact with certain medications. It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

ZEJULA 300 mg should be stored according to the instructions provided by the manufacturer, typically at room temperature and away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.